GW501516 GW501516
Dragon Pharma

GW501516

90.00 USD

CARDARINE 20 MG
Category: PPAR Receptor Agonist
Package: 100 pills (20 mg/pill)
Brand: Dragon Pharma
Purpose: N/A
Laboratory Tested: View Results

Shipping From:
International
U.S. Domestic

GW501516 Detailed

DRAGON PHARMA GW501516

GW501516, commonly known as Cardarine, is a selective androgen receptor modulator (SARM) that gained popularity for its potential benefits in enhancing endurance and promoting fat loss. Despite being initially developed for treating metabolic and cardiovascular diseases, it is not approved for medical use.

DRUG COMPOSITION

The active ingredient in GW501516 is the compound with the same name, which acts on peroxisome proliferator-activated receptors (PPARs) in the body.

LAB TEST REPORT

gw501516 lab test report

PHARMACEUTICAL FORM

GW501516 is typically available in oral form, commonly as capsules or tablets, for convenient administration.

PHARMACEUTICAL GROUP AND ATC CODE

GW501516 belongs to the group of peroxisome proliferator-activated receptor agonists. However, it is essential to note that it is not classified under the Anatomical Therapeutic Chemical (ATC) system, as it is not approved for medical use.

PHARMACOLOGICAL PROPERTIES

Cardarine exerts its effects by activating PPAR-delta receptors, which play a role in regulating various metabolic processes. It has been studied for its potential benefits in improving endurance, increasing fat metabolism, and enhancing cardiovascular health.

PROFILE

  • Chemical name: N/A
  • Chemical formula: N/A
  • Percentage of anabolic activity: N/A
  • Percentage of androgenic activity: N/A
  • Active half life: n/a
  • Recommended dosage: n/a
  • Acne: n/a
  • Bloating (water retention): n/a
  • HBR: n/a
  • Hepatic toxicity: n/a
  • Aromatization: n/a

THERAPEUTICAL INDICATIONS

GW501516 is not approved for therapeutic use, and its potential applications are primarily explored in preclinical and experimental settings. It is not prescribed or recommended for medical conditions.

DOSES AND METHOD OF ADMINISTRATION

In experimental settings, doses of GW501516 vary, and its administration is typically oral. However, due to its unregulated status, there are no standardized doses for human consumption.

CYCLE/STACKING

The usage of GW501516 is often discussed in the context of cycles, where individuals may incorporate it into their fitness or bodybuilding regimen. However, specific cycles and duration are not universally agreed upon due to the lack of regulatory approval.

POST CYCLE THERAPY

Post-cycle therapy (PCT) protocols are commonly associated with anabolic steroid use, and GW501516, being a SARM, may not require traditional PCT. However, individual responses may vary, and consultation with healthcare professionals is advised.

SIDE EFFECTS

While GW501516 has shown promise in research, its safety and potential long-term side effects in humans remain uncertain. Reported side effects in animal studies include potential links to cancer, but further research is needed.

CONTRAINDICATIONS

As GW501516 is not approved for medical use, there are no established contraindications. However, its unregulated status raises concerns about safety and potential risks.

OVERDOSE

The effects of an overdose of GW501516 are not well-documented. Due to its experimental nature, individuals are strongly discouraged from exceeding recommended or speculated doses.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Given its unregulated status and potential safety concerns, individuals should exercise caution and be aware of the lack of oversight in terms of purity and dosage accuracy in products available on the market.

INTERACTIONS WITH OTHER DRUGS

Specific drug interactions with GW501516 are not well-established, but caution is advised, especially when considering its use alongside other substances.

PRESENTATION, PACKAGING

100 tablets in sachet.

STORAGE

GW501516 should be stored according to the guidelines provided with the specific product. Typically, it is recommended to store it in a cool, dry place away from direct sunlight.

DELIVERY TO THE USA

GW501516 is available for secure and discreet delivery to the USA through authorized supplier - Steroid.biz.

LEGAL STATUS

GW501516 is not approved for medical use, and its legality for personal use varies by jurisdiction. It is essential to be aware of and comply with local regulations regarding the purchase and use of this compound.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

No reviews found

Please log in to write GW501516 review.

Related Offers
-30% OFF
πŸ“„ Lab Tested!
US Domestic & International
Accutane
Dragon Pharma, Europe

ISOTRETINOIN 20 MG
Category: Retinoid
Package: 100 pills (20 mg/pill)
Brand: Dragon Pharma, Europe
Purpose: Treats Severe Acne
Laboratory Tested: View Results

65.00 USD  
-30% OFF
πŸ“„ Lab Tested!
US Domestic & International
Anavar 10
Dragon Pharma, Europe

OXANDROLONE 10 MG
Category: Androgen; Anabolic Steroid
Package: 100 pills (10 mg/pill)
Brand: Dragon Pharma, Europe
Purpose: Cutting Cycle
Laboratory Tested: View Results

100.00 USD  
-30% OFF
πŸ“„ Lab Tested!
US Domestic & International
Arimidex
Dragon Pharma, Europe

ANASTROZOLE 1 MG
Category: Aromatase Inhibitor; Antiestrogen
Package: 100 pills (1 mg/pill)
Brand: Dragon Pharma, Europe
Purpose: Blocks the Aromatase Enzyme
Laboratory Tested: View Results

60.00 USD  
πŸ“„ Lab Tested!
US Domestic & International
Aromasin
Dragon Pharma, Europe

EXEMESTANE 25 MG
Category: Aromatase Inhibitor; Antiestrogen
Package: 100 pills (25 mg/pill)
Brand: Dragon Pharma, Europe
Purpose: Lower Estrogen Levels

105.00 USD  
US Domestic & International
Cheque Drops
Dragon Pharma, Europe

MIBOLERONE 250 MCG
Category: Oral Anabolic Androgenic Steroid
Package: 100 pills (250 mcg/pill)
Brand: Dragon Pharma, Europe
Purpose: Mass, Bulking, Strength Cycle

50.00 USD  

Add in Cart - Product(s)

Close Button
Empty

Total Cost: